Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.The European guideline on management of major bleeding and coagulopathy following trauma: fourth editionThe critical care management of spontaneous intracranial hemorrhage: a contemporary reviewPATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial.The persisting burden of intracerebral haemorrhage: can effective treatments be found?Association Factors for CT Angiography Spot Sign and Hematoma Growth in Korean Patients with Acute Spontaneous Intracerebral Hemorrhage : A Single-Center Cohort Study.Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhageTreatment targets in intracerebral hemorrhage.Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Should anticoagulation be resumed after intracerebral hemorrhage?Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studiesRApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial.Sex-related differences in primary intracerebral hemorrhageSpontaneous Intracerebral Hemorrhage: Management.Impact of intraventricular hemorrhage upon intracerebral hematoma expansion.Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.Intracerebral hemorrhage: a review of coagulation function.Emergency neurological life support: intracerebral hemorrhage.Monitoring of hematological and hemostatic parameters in neurocritical care patients.Emergency Neurological Life Support: Intracerebral Hemorrhage.Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.Up-regulation of Vps4A promotes neuronal apoptosis after intracerebral hemorrhage in adult rats.Up-Regulation of KPNB1 Involves in Neuronal Apoptosis Following Intracerebral Hemorrhage in Adult Rats.A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage.Predictors of hematoma expansion predictors after intracerebral hemorrhage.Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis.Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage.Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke.Variation in a locus linked to platelet aggregation phenotype predicts intraparenchymal hemorrhagic volume.Emergency Neurological Life Support: Intracerebral Hemorrhage.Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage.The O-GlcNAc Modification of CDK5 Involved in Neuronal Apoptosis Following In Vitro Intracerebral Hemorrhage.Risk factors for 1-year mortality in patients with nontraumatic intracranial hemorrhage requiring intensive care.Spontaneous intracerebral hemorrhage with antiplatelets/anticoagulants/none: a comparison analysis.Up-regulation of c-Fos associated with neuronal apoptosis following intracerebral hemorrhage.
P2860
Q21092902-3FDF7230-0C74-4A68-B4DD-2C4F9121D12AQ27339343-B569BD8B-706C-4D27-8EE9-821E3B281BD2Q28067962-F0971471-E5C6-438D-B3B4-A8F6DF65A4EBQ33542800-A2FA5E21-328F-443D-B3B5-F6F33C4E032AQ33728274-28EB9114-8600-416D-A955-625A678DA2A6Q34447650-DA40D618-B6EF-4C4C-96F0-1B2859170EBDQ35208004-C3331FD8-E0DB-4065-9642-3252732A4D44Q35648063-7905513D-6BD0-4A14-860B-AF3F27607726Q35711431-510B1B19-E63A-44D6-8BBC-56BB0CBA846AQ36933765-8535468B-1709-43F6-BC48-902614B56FA8Q36984232-F2AD3F73-6CE3-4043-98B6-937B61CC8E0EQ37028458-4525A6F9-EFA2-4AC5-ACAC-0600C1171917Q37113380-BC8DFB77-F5DC-4FC2-84BB-114DA4237FF8Q37640888-2BA2DDB6-3B44-4726-B810-2B11E880B8C4Q37794843-44A979DC-32BD-4173-9999-265F8CE58230Q37978627-46DED0F2-EE8A-41F1-AE17-47EF07F5D834Q38035818-D2D109E8-ACE9-464B-8E17-3A8BE891FD40Q38042353-406CAD78-A5A1-4565-B549-E9BFAE2BF243Q38248152-904734D9-6725-46C6-90D4-F0EE5A3C4AB4Q38599754-8CA2B2AD-2A6F-45EA-9155-CADB8965F299Q38764867-55049ACF-9379-46E5-914A-38EB00AA3994Q39228058-47890694-A1E9-4333-B3AD-5C633E53050AQ40390596-BE333CCD-3E0A-4DDB-9F9E-117EBEA747B4Q42481486-BDC72C60-9839-412C-97F9-E649F8D70EE0Q42545904-C8885562-EC54-48EE-BE61-DC05D807622BQ46191310-E9D8E039-A223-40CE-AF03-22FCF4527EB4Q47099027-5170A84E-3129-49FD-8D71-FF04E2C3F8CBQ47195796-79416A5B-2E5C-4FB7-B36E-E3935E2A4218Q47953596-FBDE81A5-EA4E-4ACE-8086-DA0EA864BAA5Q47980769-FD3556F9-2FCF-478D-8EE5-9BC171CD77DEQ48111775-BB98F961-1BA3-44CC-AC3C-439737D1CD87Q48346851-DEE80295-660B-44F6-A81C-A31A2D6C7BECQ48668884-0287C6CC-FB33-4CCC-932D-E898A3BF80B5Q50993001-77A2B882-141F-4195-8548-ADB841614957Q53067913-61816695-25AB-4757-B7A4-8CC2137DCDEFQ53401841-72D86492-79FE-46CE-BD9A-26518A0D690D
P2860
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
@en
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.
@nl
type
label
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
@en
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.
@nl
prefLabel
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
@en
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.
@nl
P2093
P2860
P1433
P1476
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH
@en
P2093
B L Cucchiara
CHANT Investigators
L H Sansing
S E Kasner
P2860
P304
P356
10.1212/01.WNL.0000342709.31341.88
P407
P577
2009-01-07T00:00:00Z